Αρχική World News Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based... World News Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP Από Ogkologos - 22 Σεπτεμβρίου, 2026 108 0 Facebook Twitter Google+ Pinterest WhatsApp Updated results after additional follow-up in the CUPISCO study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Fruquintinib 13 Μαΐου, 2024 EMA Recommends Granting a Marketing Authorisation for Tepotinib 23 Δεκεμβρίου, 2021 FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell... 22 Ιουλίου, 2026 ‘Will cancer make me infertile?’ – That Cancer Conversation 12 Μαΐου, 2021 Φόρτωση περισσοτέρων HOT NEWS Greater Severity of Adverse Events in Women Across Multiple Anticancer Treatment... Smoking among young adults increased by 25% during first lockdown Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated,... New Treatment Helps Survivors Regain Sensation After Breast Cancer